• New Insight: Role of Contract Research Organizations in Retina w/ Brad Doerschuk

  • Feb 29 2024
  • Duración: 30 m
  • Podcast

New Insight: Role of Contract Research Organizations in Retina w/ Brad Doerschuk

  • Resumen

  • In the medical community, a revolving cast of players plays a pivotal role in advancing scientific discovery and enhancing patient outcomes. During the research stage, a collaborative team effort, from the clinical trial sponsors to research sites and patient populations, is essential to ensure smooth progress and sustain momentum toward the finish line.

    The latest episode of New Insight with Veeral Sheth, MD features a conversation with Brad Doerschuk, the CEO of InFocus Clinical Research, on the important role of contract research organizations (CROs) in retina and the field of ophthalmology.

    In their conversation, Sheth and Doerschuk shed light on the role of CROs in managing clinical trials, dive into the evolution of the retina space in recent decades, and describe the challenges in recruiting for trials of new agents.

    Episode Highlights
    0:00 Introduction
    0:52 What is a CRO?
    2:13 Development of InFocus
    6:45 Discussing the retina pipeline
    11:46 Recruitment challenges, solutions
    15:50 Developing new clinical trial sites
    18:19 Relationship between investigators, CROs
    19:56 Shift in FDA guidance
    23:14 New trial endpoints
    25:16 Conclusion

    Every episode of New Insight is available on HCPLive.com and be sure to subscribe to our channel on Spotify and Apple Podcasts. Please direct any podcast-related inquiries to show producer Connor Iapoce at ciapoce@mjhlifesciences.com.
    Más Menos
activate_WEBCRO358_DT_T2

Lo que los oyentes dicen sobre New Insight: Role of Contract Research Organizations in Retina w/ Brad Doerschuk

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.